Skip to content

Evaluating Skin Barrier Changes in Food Allergy

Search Clinical Trials

Trial Objectives


Food allergies are complex, and researchers are studying new ways to predict who might develop allergies in the future. In this study, researchers are trying to determine if skin reactions during an oral food challenge can predict food allergies. They also are evaluating if a biologic called omalizumab, which is currently approved to treat asthma, can help people with food allergies.

Researchers are comparing the skin of people with food allergies to those without food allergies in the first phase of the study. Volunteers with food allergies will undergo 2 oral food challenges and will receive 4 months of treatment with omalizumab. At clinic visits, skin tape strips will be collected to measure a number of markers of overall skin health to see if they improve. Volunteers without food allergies will have skin tape strips collected at a single clinic visit, which will help provide a comparison for researchers.

Who Can Participate


Adults and children with or without food allergies

Age: 1-55 Gender: Any

Estimated Time Commitment


13 visits over approximately 5 months. Participants without food allergies will only need 1 visit.

Payment & Reimbursement


Payment: Provided

Travel Reimbursement: Not Available

Trial Contact


For more information, contact:

Susan Leung
303.398.1409

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


National Jewish Health & Genentech

Principal Investigators

Donald Y M Leung

Donald Y M Leung, MD, PhD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required